Aytu BioScience
Price & Volume
Stats
See moreOpen | $2.45 |
Previous Close | $2.37 |
Day Range | $2.45-$2.49 |
52W Range | $0.95-$2.82 |
Market Cap | $23.3M |
Shares Short | 461,813 |
Financials
See moreRevenue (12 Mos) | $66.3M |
Revenue Growth (YoY) | 3.7% |
Gross Profit (12 Mos) | $45.8M |
Diluted EPS | -$2.26 |
News
See moreYahoo Finance • 16 days ago
Aytu outlines EXXUA launch targeting $22B MDD market while streamlining ADHD portfolio
Yahoo Finance • 16 days ago
Aytu BioPharma GAAP EPS of -$2.93 misses by $2.88, revenue of $15.1M misses by $2.82M
Yahoo Finance • 17 days ago
Aytu BioPharma FQ4 2025 Earnings Preview
Yahoo Finance • 3 months ago
Lake Street Sees Big Upside for Aytu Biosciences (AYTU) After EXXUA Acquisition
About
CEO | Mr. Joshua R. Disbrow |
CFO | Mr. Ryan J. Selhorn CPA |
Address | Denver Corporate Center III, Denver, CO, United States, 80237 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 82 |
